Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Isabelle M. E. Lacroix"'
Publikováno v:
International Journal of Molecular Sciences, Vol 15, Iss 11, Pp 20846-20858 (2014)
The inhibition of the enzyme dipeptidyl-peptidase IV (DPP-IV) is an effective pharmacotherapeutic approach for the management of type 2 diabetes. Recent findings have suggested that dietary proteins, including bovine α-lactalbumin, could be precurso
Externí odkaz:
https://doaj.org/article/80ac240062f44ea384ff8ee19946570b
Publikováno v:
Food & Function. 8:701-709
In recent years, peptides derived from a variety of dietary proteins have been reported to exhibit inhibitory activity against the dipeptidyl-peptidase IV (DPP-IV) enzyme, a target in the management of type 2 diabetes. While much attention has been g
Autor:
Kento Imai, Vincenzo Fogliano, Isabelle M. E. Lacroix, Irene Dávalos Terán, Chibuike C. Udenigwe
Publikováno v:
Journal of food biochemistry, 44(2)
Journal of food biochemistry 44 (2020) 2
Journal of food biochemistry 44 (2020) 2
Bioinformatics was applied for strategic processing of yellow mealworm (Tenebrio molitor) proteins to produce dipeptidyl peptidase (DPP)-IV inhibiting peptides. In silico analysis of 384 mealworm proteins revealed structural proteins as better precur
Publikováno v:
International Journal of Food Science and Technology, 54(3), 696-704
International Journal of Food Science and Technology 54 (2019) 3
International Journal of Food Science and Technology 54 (2019) 3
Food-derived peptides are known to possess inhibitory activity against the dipeptidyl-peptidase IV (DPP-IV) enzyme, a target in the management of type 2 diabetes. While proteins from commonly consumed food commodities have been investigated as precur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834e0fe27ae53b3b38cdf212a0eb2294
https://research.wur.nl/en/publications/investigation-into-the-potential-of-commercially-available-lesser
https://research.wur.nl/en/publications/investigation-into-the-potential-of-commercially-available-lesser
Publikováno v:
Trends in Food Science & Technology. 54:1-16
Background Diabetes, which currently affects 1 in 11 adults, is considered one of the biggest worldwide health crises of the 21st century. Over the last decade, synthetic inhibitors of the enzyme dipeptidyl-peptidase IV (DPP-IV) have emerged as an ef
Publikováno v:
Journal of Functional Foods, Vol 21, Iss, Pp 87-96 (2016)
Inhibition of dipeptidyl-peptidase IV (DPP-IV) and angiotensin I-converting enzyme (ACE) are useful strategies for managing, respectively, diabetes and hypertension, two conditions often occurring together. In this study, debittered and non-debittere
Proteins play a fundamental role not only in sustaining life, but also in foods derived from plants and animals. Foods vary in their protein content, and even more so in the properties of those proteins. In addition to their contribution to the nutri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b495546ac858a888a52c2eab3e2de6cb
https://doi.org/10.1016/b978-0-08-100722-8.00002-4
https://doi.org/10.1016/b978-0-08-100722-8.00002-4
Publikováno v:
Peptides. 54:39-48
Inhibition of the enzyme dipeptidyl peptidase (DPP)-IV is one of the strategies used for the treatment of type 2 diabetes. In the present study, pepsin-treated whey protein isolate (WPI) and α-lactalbumin displaying DPP-IV inhibitory activity were f
Publikováno v:
Journal of Agricultural and Food Chemistry. 61:7500-7506
Inhibitors of the enzymes dipeptidyl peptidase (DPP)-IV and α-glucosidase are two classes of pharmacotherapeutic agents used for the treatment of type 2 diabetes. In the present study, whey protein isolate (WPI), α-lactalbumin, β-lactoglobulin, se
Publikováno v:
International Dairy Journal. 25:97-102
Dipeptidyl peptidase (DPP)-IV inhibitors are promising new therapies for type 2 diabetes. Currently, these inhibitors are only available as synthetic drugs. Therefore, the aim of the present study was to investigate dairy protein hydrolysates as natu